Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.63 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | LSS | P48449 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL891947 | 1.00 | CYP1A2 (0.63) | CYP1A2SIGMAR1EPHX1LSSALDH1A1 | |
| SCHEMBL9300758 | 1.00 | CYP1A2 (0.63) | CYP1A2SIGMAR1EPHX1LSSALDH1A1 | |
| SCHEMBL6751554 | 1.00 | CYP1A2 (0.63) | CYP1A2SIGMAR1EPHX1LSSALDH1A1 | |
| SCHEMBL892110 | 0.98 | CYP1A2 (0.65) | CYP1A2SIGMAR1EPHX1NAAA | |
| SCHEMBL27780787 | 0.90 | CYP1A2 (0.59) | CYP1A2SIGMAR1EPHX1 | |
| SCHEMBL19692221 | 0.90 | CYP1A2 (0.46) | CYP1A2EPHX1LSSALDH1A1MEN1 | |
| SCHEMBL1681647 | 0.90 | CYP1A2 (0.46) | CYP1A2EPHX1LSSALDH1A1MEN1 | |
| SCHEMBL19692427 | 0.90 | CYP1A2 (0.46) | CYP1A2EPHX1LSSALDH1A1MEN1 | |
| SCHEMBL11169649 | 0.89 | CYP1A2 (0.63) | CYP1A2SIGMAR1 | |
| SCHEMBL60056 | 0.89 | CYP1A2 (0.63) | CYP1A2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9261783-B2 | Fluorinated ester monomer, making method, fluorinated ester polymer, and difluorohydroxycarboxylic acid | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-02-16 | — | — | US | disclosed |
| US-8697903-B2 | Fluorinated ester monomer, making method, fluorinated ester polymer, and difluorohydroxycarboxylic acid | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-04-15 | — | — | US | disclosed |
| US-20140051024-A1 | FLUORINATED ESTER MONOMER, MAKING METHOD, FLUORINATED ESTER POLYMER, AND DIFLUOROHYDROXYCARBOXYLIC ACID | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-02-20 | — | — | US | disclosed |
| US-20120083580-A1 | FLUORINATED ESTER MONOMER, MAKING METHOD, FLUORINATED ESTER POLYMER, AND DIFLUOROHYDROXYCARBOXYLIC ACID | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083580-A1 | FLUORINATED ESTER MONOMER, MAKING METHOD, FLUORINATED ESTER POLYMER, AND DIFLUOROHYDROXYCARBOXYLIC ACID | ARF1, FFAR3, RFC3 | CYP1A2 3069/4885SIGMAR1 3475/4885EPHX1 263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.